Business
-
Actavis says that it will launch 0.25 mg and 0.5 mg vials of its generic budesonide inhalation suspension immediately after the United States District Court for the District of New Jersey ruled that the products… Read more . . .
-
Inhalation experts from the Woolcock Institute of Medical Research and the University of Sydney have launched a new company called Pulmatix to provide analytical services ranging from evaluation of APIs and formulations in respiratory cells… Read more . . .
-
Savara Pharmaceuticals has received additional funding for Phase 2 development of its AeroVanc vancomycin inhalation powder for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in cystic fibrosis patients. The company brought its Series B… Read more . . .
-
Pearl Therapeutics was awarded the 2013 Drug Delivery Partnerships (DDP) Innovation Award for its co-suspension formulation technology, according to the company. The company is developing several metered dose inhalation products using the technology. President and… Read more . . .
-
The University of East Anglia (UEA) Medical School will fund research to adapt a MRSA-specific antibiotic being developed by Procarta Biosystems into a nasal spray for decolonization of patients before major surgery, according to Procarta.… Read more . . .
-
OptiNose has selected Pharma Tech Industries (PTI) to fill capsules, load cartridges, and package completed delivery systems for NDA batches of its dry powder intranasal sumatriptan, according to Pharma Tech. In November 2012, OptiNose announced… Read more . . .
-
Prevacus, Inc., a 2012 spin-out from Florida State University, has entered into an agreement with The Institute for the Commercialization of Public Research for funding to support clinical development of Prevasol nasal spray. According to… Read more . . .
-
According to Savara Pharmaceuticals, the company has created a Clinical Advisory Board to provide advice on the development of AeroVanc vancomycin hydrochloride inhalation powder for the treatment of MRSA lung infections in patients with cystic… Read more . . .
-
The Bluetooth Special Interest Group (SIG) has named Asthmapolis the winner in the Product Category of the Bluetooth Breakthrough Awards. The awards recognize innovative products and apps that use Bluetooth wireless technology. Asthmapolis, which uses… Read more . . .
-
Smartinhaler developer Nexus6 has raised NZ$1.6 million (US$1.34 million) from existing investors plus NZ$3 (US$2.5 million) from BioScience Managers, with additional funding expected to bring the total to NZ$5 million by the close of the… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland